Fig. 4From: Identification of differentially expressed proteins and clinicopathological significance of HMGB2 in cervical cancerImmunohistochemical expression of HMGB2 in cervical cancer samples (CC), normal cervical samples (N) and high-grade squamous intraepithelial lesion samples (HSIL). a–f Representative immunohistochemical staining images for CC, N and HSIL. g The immunoreactive score for CC, N and HSIL. *P < 0 0.05 compared to CCBack to article page